Xu YL - Search Results

1

Prognostic value of Musashi-1 in endometrioid adenocarcinoma.

Ma L, Xu YL, Ding WJ, Shao HF, Teng YC. Ma L, et al. Among authors: xu yl. Int J Clin Exp Pathol. 2015 May 1;8(5):4564-72. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191146 Free PMC article.

2

Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.

Xu Y, Tong J, Ai Z, Wang J, Teng Y. Xu Y, et al. J Obstet Gynaecol Res. 2012 Dec;38(12):1358-66. doi: 10.1111/j.1447-0756.2012.01881.x. Epub 2012 May 21. J Obstet Gynaecol Res. 2012. PMID: 22612393

3

Influence of epidermal growth factor receptor inhibitor AG1478 on epithelial-mesenchymal transition in endometrial carcinoma cells.

Yan Y, Ai Z, Wang J, Xu Y, Teng Y. Yan Y, et al. Int J Gynecol Cancer. 2012 Nov;22(9):1457-62. doi: 10.1097/IGC.0b013e31826ed2be. Int J Gynecol Cancer. 2012. PMID: 23099861

4

Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers.

Zhu XL, Ai ZH, Wang J, Xu YL, Teng YC. Zhu XL, et al. Among authors: xu yl. Asian Pac J Cancer Prev. 2012;13(9):4607-11. doi: 10.7314/apjcp.2012.13.9.4607. Asian Pac J Cancer Prev. 2012. PMID: 23167388 Free article.

5

Bioinformatics analysis reveals potential candidate drugs for cervical cancer.

Ai Z, Wang J, Xu Y, Teng Y. Ai Z, et al. J Obstet Gynaecol Res. 2013 May;39(5):1052-8. doi: 10.1111/jog.12022. Epub 2013 Apr 4. J Obstet Gynaecol Res. 2013. PMID: 23551598

6

Correlation between the overexpression of epidermal growth factor receptor and mesenchymal makers in endometrial carcinoma.

Yang WN, Ai ZH, Wang J, Xu YL, Teng YC. Yang WN, et al. Among authors: xu yl. J Gynecol Oncol. 2014 Jan;25(1):36-42. doi: 10.3802/jgo.2014.25.1.36. Epub 2014 Jan 8. J Gynecol Oncol. 2014. PMID: 24459579 Free PMC article.

7

Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer.

Zhu XL, Wen SY, Ai ZH, Wang J, Xu YL, Teng YC. Zhu XL, et al. Among authors: xu yl. Mol Med Rep. 2015 Jul;12(1):55-62. doi: 10.3892/mmr.2015.3363. Epub 2015 Feb 17. Mol Med Rep. 2015. PMID: 25695263 Free PMC article.

8

Ratios of biochemical markers in peritoneal fluid to those in venous blood for the diagnosis of ruptured tubal pregnancy: A prospective study.

Zhu XL, Xue ZW, Xu YL, Wang J, Ai ZH, Teng YC. Zhu XL, et al. Among authors: xu yl. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:370-375. doi: 10.1016/j.ejogrb.2017.01.017. Epub 2017 Jan 18. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28157643

9

Topical 5-aminolevulinic acid photodynamic therapy for cervical high-grade squamous intraepithelial lesions.

Hu Y, Li Y, Xu Y, Teng Y, Chen J, Ma L. Hu Y, et al. Photodiagnosis Photodyn Ther. 2022 Sep;39:103037. doi: 10.1016/j.pdpdt.2022.103037. Epub 2022 Jul 26. Photodiagnosis Photodyn Ther. 2022. PMID: 35905829 Free article.

10

Effects of 5-aminolevulinic acid photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HR-HPV infections.

Li Y, Chen J, Hu Y, Xu Q, Jiang R, Teng Y, Xu Y, Ma L. Li Y, et al. Front Med (Lausanne). 2024 Feb 9;10:1301440. doi: 10.3389/fmed.2023.1301440. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38404461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters